Treatment of Fabry’s Disease with the Pharmacologic Chaperone MigalastatDominique P. Germain, Raphael Schiffmann, Derralynn Hughes et al.|New England Journal of Medicine|2016Cited by 555
Diagnosis and management of pemphigus: Recommendations of an international panel of expertsDédée F. Murrell, Pilar Iranzo, Ayşe Akman Karakaş et al.|Journal of the American Academy of Dermatology|2018Cited by 373
Updated S2K guidelines on the management of pemphigus vulgaris and foliaceus initiated by the european academy of dermatology and venereology (EADV)P. Joly, Enno Schmidt, Barbara Horváth et al.|Journal of the European Academy of Dermatology and Venereology|2020Cited by 332
Updated<scp>S2</scp>K guidelines for the management of bullous pemphigoid initiated by the European Academy of Dermatology and Venereology (<scp>EADV</scp>)Luca Borradori, Gang Wang, Nina van Beek et al.|Journal of the European Academy of Dermatology and Venereology|2022Cited by 247
In Vitro and In Vivo Expression of Interleukin-1α and Tumor Necrosis Factor-α mRNA in Pemphigus Vulgaris: Interleukin-1α and Tumor Necrosis Factor-α are Involved in AcantholysisClaudio Feliciani, Daniel N. Sauder, Paola Toto et al.|Journal of Investigative Dermatology|2000Cited by 182